Roivant Sciences (ROIV) EBT Margin Growth (3y) (2023 - 2026)
Powered by 
Analysis
Roivant Sciences (ROIV) EBT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 6,691.00 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -2,054.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 8,006.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 9,980.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -5,319.00 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 31,363.00 |
| 10 | Roivant Sciences | 25.22 Bn | 25.22 Bn | 1.16 Mn | -1.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.89 Mn |
| Dec 31, 2025 | -943,642.00 |
| Sep 30, 2025 | -762,030.00 |
| Jun 30, 2025 | -430,964.00 |
| Dec 31, 2024 | -85,489.00 |
| Sep 30, 2024 | -340,380.00 |
| Jun 30, 2024 | 105,975.00 |
| Dec 31, 2023 | 2.65 Mn |
| Sep 30, 2023 | -262,754.00 |
| Jun 30, 2023 | -107,933.00 |